Ennis & Ennis, P.A. Investigates Pradaxa Bleed Claims

Ennis & Ennis, P.A. Announces Free, Nationwide, Confidential Consultations for Pradaxa Bleed Victims (PRWEB) February 08, 2012 On December 7, 2011, the U. S. Food and Drug Administration (FDA) issued a Safety Communication reporting that it was investigating reports of serious and fatal bleeds in patients taking Pradaxa. Pradaxa is a blood thinning medication (anticoagulant) used to reduce the risk of stroke and blood clots in patients with non-valvular atrial fibrillation (AF). David Ennis of Ennis & Ennis, P.A. states, “We are investigating claims that involve serious and/or fa
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations